1. Home
  2. AAME vs KPTI Comparison

AAME vs KPTI Comparison

Compare AAME & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAME
  • KPTI
  • Stock Information
  • Founded
  • AAME 1968
  • KPTI 2008
  • Country
  • AAME United States
  • KPTI United States
  • Employees
  • AAME N/A
  • KPTI N/A
  • Industry
  • AAME Life Insurance
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAME Finance
  • KPTI Health Care
  • Exchange
  • AAME Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • AAME 46.3M
  • KPTI 44.5M
  • IPO Year
  • AAME N/A
  • KPTI 2013
  • Fundamental
  • Price
  • AAME $3.08
  • KPTI $5.92
  • Analyst Decision
  • AAME
  • KPTI Buy
  • Analyst Count
  • AAME 0
  • KPTI 6
  • Target Price
  • AAME N/A
  • KPTI $39.80
  • AVG Volume (30 Days)
  • AAME 25.2K
  • KPTI 221.8K
  • Earning Date
  • AAME 08-12-2025
  • KPTI 08-11-2025
  • Dividend Yield
  • AAME 0.65%
  • KPTI N/A
  • EPS Growth
  • AAME N/A
  • KPTI N/A
  • EPS
  • AAME 0.10
  • KPTI N/A
  • Revenue
  • AAME $198,977,000.00
  • KPTI $137,269,000.00
  • Revenue This Year
  • AAME N/A
  • KPTI $2.18
  • Revenue Next Year
  • AAME N/A
  • KPTI $11.28
  • P/E Ratio
  • AAME $29.45
  • KPTI N/A
  • Revenue Growth
  • AAME 6.98
  • KPTI N/A
  • 52 Week Low
  • AAME $1.25
  • KPTI $3.51
  • 52 Week High
  • AAME $3.37
  • KPTI $16.95
  • Technical
  • Relative Strength Index (RSI)
  • AAME 78.68
  • KPTI 72.07
  • Support Level
  • AAME $2.18
  • KPTI $3.65
  • Resistance Level
  • AAME $2.38
  • KPTI $4.35
  • Average True Range (ATR)
  • AAME 0.21
  • KPTI 0.50
  • MACD
  • AAME 0.06
  • KPTI 0.17
  • Stochastic Oscillator
  • AAME 76.09
  • KPTI 70.06

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: